Synthesis of rhenium(I) and technetium(I) carbonyl/dithioether ligand complexes bearing 3,17β-estradiol

[1]  S. Mather.  Current Directions in Radiopharmaceutical Research and Development , 2011, Developments in Nuclear Medicine.

[2]  H. Spies,et al.  Synthesis of “3+1” mixed-ligand oxorhenium(V) complexes containing modified 3,17β-estradiol , 1996 .

[3]  R. Schibli,et al.  Reactions with the technetium and rhenium carbonyl complexes (NEt4)2[MX3(CO)3]. Synthesis and structure of [Tc(CN-But)3(CO)3](NO3) and (NEt4)[Tc2(μ-SCH2CH2OH)3(CO)6] , 1996 .

[4]  P. Schubiger,et al.  Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate. , 1996, Bioconjugate chemistry.

[5]  D. Hughes,et al.  Rhenium Carbonyl Complexes of .beta.-Estradiol Derivatives with High Affinity for the Estradiol Receptor: An Approach to Selective Organometallic Radiopharmaceuticals , 1995 .

[6]  R. Schibli,et al.  Metal carbonyl syntheses XXII. Low pressure carbonylation of [MOCl4]− and [MO4]−: the technetium(I) and rhenium(I) complexes [NEt4]2[MCl3(CO)3]☆ , 1995 .

[7]  M. Welch,et al.  Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate. , 1994, Bioconjugate chemistry.

[8]  A. Vessières,et al.  Syntheses and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship. , 1992, Journal of medicinal chemistry.

[9]  M. Welch,et al.  Steroid Hormone Receptors as Targets for Diagnostic Imaging , 1996 .

[10]  J. Katzenellenbogen,et al.  A short, stereoselective route to 16.alpha.-(substituted-alkyl)estradiol derivatives , 1987 .

[11]  H. Wagner,et al.  Technetium in chemistry and nuclear medicine , 1983 .